# Gottfried E. Konecny

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gottfried-e-konecny/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,339 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 59 |
| i10-index | 126 |
| Last Known Institution | University of California, Los Angeles |
| OpenAlex ID | https://openalex.org/A5062837404 |
| ORCID iD | https://orcid.org/0000-0001-6083-657X |
| Works | 415 |

## Researcher papers

Showing 12 of 13.

- [Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes](https://scholariq.org/papers/definition-and-impact-of-pathologic-complete-response-on-prognosis-after/)
- [Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/rucaparib-maintenance-treatment-for-recurrent-ovarian-carcinoma-after-response/)
- [Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial](https://scholariq.org/papers/rucaparib-in-relapsed-platinum-sensitive-high-grade-ovarian-carcinoma-ariel2/)
- [Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/ovarian-cancer-version-2-2020-nccn-clinical-practice-guidelines-in-oncology/)
- [Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer](https://scholariq.org/papers/multiple-independent-variants-at-the-tert-locus-are-associated-with-telomere/)
- [Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer](https://scholariq.org/papers/mirvetuximab-soravtansine-in-fr-positive-platinum-resistant-ovarian-cancer/)
- [<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma](https://scholariq.org/papers/i-brca-i-reversion-mutations-in-circulating-tumor-dna-predict-primary-and/)
- [Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer](https://scholariq.org/papers/prognostic-and-therapeutic-relevance-of-molecular-subtypes-in-high-grade-serous/)
- [NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022](https://scholariq.org/papers/nccn-guidelines-insights-ovarian-cancer-version-3-2022/)
- [GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer](https://scholariq.org/papers/gwas-meta-analysis-and-replication-identifies-three-new-susceptibility-loci-for/)
- [Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2](https://scholariq.org/papers/antitumor-activity-and-safety-of-the-parp-inhibitor-rucaparib-in-patients-with/)
- [PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions](https://scholariq.org/papers/parp-inhibitors-for-brca1-2-mutated-and-sporadic-ovarian-cancer-current-practice/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [University of California, Los Angeles](https://scholariq.org/institutions/university-of-california-los-angeles/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.